What is Vemlidy (tenofovir alafenamide) used for?
Vemlidy is a brand name for tenofovir alafenamide (TAF). It’s used to treat chronic hepatitis B, specifically to manage the hepatitis B virus (HBV) infection in people who need antiviral therapy.
Who typically takes Vemlidy?
Vemlidy is prescribed for adults with chronic HBV and for pediatric patients (age depends on the specific product labeling and indication). It’s used when the goal is to suppress HBV replication and reduce liver-related complications over time.
How does Vemlidy work?
Vemlidy is an antiviral medicine that blocks HBV replication. It belongs to the nucleotide reverse transcriptase inhibitor (NRTI) class, targeting the viral enzyme needed for virus replication.
Is Vemlidy the same as Viread?
No. Vemlidy (TAF) and Viread (tenofovir disoproxil fumarate, TDF) are both tenofovir-based treatments for HBV, but they are different formulations with different dosing and safety profiles.
Common patient question: Is it for HIV?
Vemlidy is for hepatitis B. Tenofovir-based drugs can have activity against HIV as well, but Vemlidy is not used as an HIV treatment in standard HBV-only prescribing contexts.
If you meant “Vemlidy uses” as in what it’s indicated for by specific patient group (adult vs child, compensated vs decompensated liver disease, treatment-naïve vs previously treated), tell me the patient age and whether the person has HIV or liver cirrhosis, and I can narrow it down.